Skip to the page content
Your donations
Passes our checks

Cancer Research America Nfcr Inc

EIN 04-2531031 · Rockville, MD

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthGood89 out of 100GovernanceStrong100 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

SEE SCHEDULE O

Income
$11.1 million
Spending
$9.8 million
Spent on programs
74%
Reserves
6.9 months of spending
Largest source of income
donations and private grants, 94%
Employees
16
Volunteers
70
Highest pay
$557,229, president/ceo

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Good: 89 out of 100. Higher than 74% of charities in its peer group (medical research, $10m to $100m).

  • Reserves

    28 of 35

    Spendable reserves would cover 6.9 months of spending.

  • Debt

    16 of 20

    It owes 24% of what it owns.

  • Living within its means

    15 of 15

    Income exceeded spending by 12% of income.

  • Income trend

    15 of 15

    Income rose 21% on the year before.

  • Spending floor

    15 of 15

    74% of spending went to programs and raising each dollar of donations cost 17 cents.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Strong: 100 out of 100. Higher than 45% of charities in its peer group (medical research, $10m to $100m).

  • Independent board

    25 of 25

    7 of 7 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    8 of 8

    Has a written whistleblower policy.

  • Record keeping policy

    7 of 7

    Has a written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    10 of 10

    Gave the board a copy of this return before filing it.

  • Pay set independently

    5 of 5

    Sets its chief executive's pay through independent review and comparison.

  • Independent check of accounts

    15 of 15

    Its accounts were audited by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (2)
  1. $5.0 million spent. Scientific Advancement: In 2023-2024, NFCR funded 37 scientists conducting groundbreaking research across more than 15 cancer types. This investment fuels basic, translational, and clinical research, expanding the global knowledge base and accelerating new therapeutic approaches. Clinical Impact: NFCR-supported discoveries advanced 7 therapies into clinical trial phases (5 Phase 1, 2 Phase 2), bringing innovative treatments closer to patients in need. Innovation Translation: NFCR contributed to breakthroughs in liquid biopsy technologies for early detection and precision oncology approaches, supporting innovations that improve patient outcomes and inform prevention strategies. Public Health Outreach: In 2024, NFCR distributed over 250 Cancer Prevention Kits, directly reaching over 1000 individuals through about 100 community events nationwide. These resources empower the public to adopt cancer-preventive behaviors and pursue timely screenings. Marketing & Communications Impact: NFCR's marketing and communications strategies amplify the reach, engagement, and influence of our scientific funding and public health initiatives, ensuring that program results translate into broad awareness, donor action, and sustained mission support. Owned & social channels: NFCR runs an active content ecosystem, including a blog, and media gallery with two YouTube series (Making Sense of Science and Cancer-Fighting Lifestyle), the All Things CANCER podcast, and an email newsletter sign-up for ongoing education and donor stewardship. Public education assets: NFCR publishes accessible prevention resources, including the downloadable Cancer Prevention & Early Detection Kit and Cancer Screening Guidelines, which reinforce behavior change and early detection messaging. Thought leadership & convenings: The annual NFCR Global Summit & Award Ceremonies serve as a collaboration engine where "new partnerships form every year," expanding the impact of NFCR's science communications beyond owned channels. Fundraising communications tied to outcomes: Event communications (e.g., Daffodils & Diamonds) publicly report results linking storytelling to tangible support for research. Mission context for all outreach: NFCR consistently communicates scale and stewardship - $420M+ funded and 5.3M+ lifetime donors in progress/annual reports and "About" materials, anchoring all marketing in mission impact. Through global collaboration, NFCR is making unique impact on a new and accelerated path to cures. NFCR envisions a world without cancer!
  2. $2.2 million spent. NFCR provides the public with free materials containing valuable information on the most up-to-date cancer preventive measures, treatment options, and diagnostic tools. Our powerful message has been mailed annually to households, reaching over 235,000 email subscribers and tens of thousands of individuals through our social media channels (Twitter and Facebook) and through our website and blogs, helps to assure that fewer of today's healthy individuals will get cancer and more of today's cancer patients will become tomorrow's cancer survivors. Our public education materials include early cancer detection guide, cancer prevention kits, recipes for healthy living, electronic and printed newsletters, the latest cancer headlines, and in-depth online cancer information.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated November 6, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2024.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since April 2010.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated November 4, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.